Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medtronic Inc (MDT)

Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medtronic Inc BUILDING TWO PARKMORE BUSINESS PARK WEST GALWAY L2 H91 IRL

www.medtronic.com Employees: 95,000 P: 353-1438-1700

Sector:

Medical

Description:

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

Key Statistics

Overview:

Market Capitalization, $K 124,701,504
Enterprise Value, $K 150,999,504
Shares Outstanding, K 1,282,014
Annual Sales, $ 33,537 M
Annual Net Income, $ 4,662 M
Last Quarter Sales, $ 8,961 M
Last Quarter Net Income, $ 1,374 M
EBIT, $ 8,114 M
EBITDA, $ 10,975 M
60-Month Beta 0.71
% of Insider Shareholders 0.26%
% of Institutional Shareholders 82.06%
Float, K 1,278,681
% Float 99.74%
Short Interest 18,975
Short Float 1.48%
Short Volume Ratio 0.43

Growth:

1-Year Return 19.29%
3-Year Return 25.15%
5-Year Return -16.96%
5-Year Revenue Growth 15.99%
5-Year Earnings Growth 19.61%
5-Year Dividend Growth 29.63%

Per-Share Information:

Most Recent Earnings 1.36 on 11/18/25
Next Earnings Date 02/17/26
Earnings Per Share ttm 5.63
EPS Growth vs. Prev Qtr 7.94%
EPS Growth vs. Prev Year 7.94%
Annual Dividend & Yield 2.82 (2.90%)
Annual Dividend & Yield (Fwd) 2.84 (2.91%)
Most Recent Dividend 0.710 on 12/26/25
Next Ex-Dividends Date 12/26/25
Dividend Payable Date 01/16/26
Dividend Payout Ratio 49.96%
Most Recent Split 2-1 on 09/27/99

MDT Ratios

Ratio
Price/Earnings ttm 17.31
Price/Earnings forward 17.26
Price/Earnings to Growth 2.57
Return-on-Equity % 14.86%
Return-on-Assets % 7.96%
Profit Margin % 13.90%
Debt/Equity 0.60
Price/Sales 3.73
Price/Cash Flow 12.58
Price/Book 2.56
Book Value/Share 38.11
Interest Coverage 8.72

MDT Dividends

Date Value
12/26/25 $0.7100
09/25/25 $0.7100
06/27/25 $0.7100
06/26/25 $0.7100
03/28/25 $0.7000
12/27/24 $0.7000
09/27/24 $0.7000
06/27/24 $0.7000
03/21/24 $0.6900
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar